tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
US Market

Ovid Therapeutics (OVID) Income Statement

Compare
1,335 Followers

Ovid Therapeutics Income Statement

Last quarter (Q4 2024), Ovid Therapeutics's total revenue was $76.00K, a decrease of -46.31% from the same quarter last year. In Q4, Ovid Therapeutics's net income was $-9.25M. See Ovid Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 566.00K$ 391.69K$ 1.50M$ 208.38M$ 12.62M
Gross Profit
$ 566.00K$ 391.69K$ 121.14K$ 208.38M$ 12.62M
Operating Expenses
$ 62.45M$ 59.67M$ 57.05M$ 84.17M$ 94.05M
Depreciation and Amortization
$ 0.00$ 1.60M$ 1.38M$ 237.00K$ 307.00K
EBITDA
$ -61.88M$ -57.69M$ -52.79M$ 124.40M$ -81.12M
Operating Income
$ -61.88M$ -59.28M$ -55.55M$ 124.21M$ -81.43M
Other Income/Expenses
$ 35.45M$ 6.94M$ 1.38M$ -45.69K$ 395.40K
Pretax Income
$ -26.43M$ -52.34M$ -54.17M$ 124.16M$ -81.04M
Net Income
$ -26.43M$ -52.34M$ -51.41M$ 122.83M$ -80.73M
Per Share Metrics
Basic EPS
$ -0.37$ -0.74$ -0.73$ 1.78$ -1.38
Diluted EPS
$ -0.37$ -0.74$ -0.73$ 1.78$ -1.38
Weighted Average Shares Outstanding
70.91M 70.58M 70.42M 67.48M 58.45M
Weighted Average Shares Outstanding (Diluted)
70.91M 70.58M 70.42M 68.07M 58.45M
Currency in USD

Ovid Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis